Reply to thread

They have been criminally bad in defending Allergan interests.  Allergan was poised to purchase Shire but didn't and missed out on their new dry eye product.  Now. Instead of making a deal with revance for a next gen Botox they missed that opportunity also.


They definitely seem some better or faster business advisors.